Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth During the Forecast Period (2024-2034), Evaluates DelveInsight | Amgen, Novo Nordisk A/S, Ionis Pharmaceuticals, NewAmsterdam Pharma, ResverlogixCorp, Novartis

DelveInsight's "Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Atherosclerotic Cardiovascular Disease, historical and forecasted epidemiology as well as the Atherosclerotic Cardiovascular Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Atherosclerotic Cardiovascular Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Atherosclerotic Cardiovascular Disease Market Forecast
https://www.delveinsight.com/sample-request/atherosclerotic-cardiovascular-disease-ascvd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Atherosclerotic Cardiovascular Disease Market Report:
• The Atherosclerotic Cardiovascular Disease market size was valued approximately USD 23 billion in 2022 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• As of 2022, there were 55,455,209 diagnosed cases of Atherosclerotic Cardiovascular Disease (ASCVD) in the 7MM; it is anticipated that this figure will increase at a significant CAGR from 2020 to 2034
• There are numerous medications in the Atherosclerotic Cardiovascular Disease (ASCVD) pipeline at the moment. The most prominent medications for this indication include Olpasiran, TQJ230 (pelacarsen), Ziltivekimab, and a few more
• With 26,043,092 cases, the total number of diagnosed prevalent cases of atherosclerotic cardiovascular disease (ASCVD) in the US accounted for the highest number of cases among the 7MM, and it is anticipated that this number would rise sharply in the near future due to advancements in diagnostic testing and population growth
• With 5,742,367 cases, Germany had the highest diagnosed prevalent population of atherosclerotic cardiovascular disease (ASCVD) among the European nations in 2022, followed by France with 4,351,010. However, with 3,192,649 cases in the same year, Spain had the lowest diagnosed prevalence rate among the 7MM
• In 2022, Japan was home to 8,228,510 instances of Atherosclerotic Cardiovascular Disease (ASCVD), with an expected increase through the end of 2032
• Key Atherosclerotic Cardiovascular Disease Companies: Amgen, Novo Nordisk A/S, Ionis Pharmaceuticals, NewAmsterdam Pharma, ResverlogixCorp, LIB Therapeutics, Novartis, Merck Sharp & Dohme LLC, Novartis Pharmaceuticals, BioMarin Pharmaceutical, AstraZeneca, Zhejiang Genfleet Therapeutics Co., Ltd., and others
• Key Atherosclerotic Cardiovascular Disease Therapies: Olpasiran, Ziltivekimab, Olezarsen, Obicetrapib(TA-8995), Apabetalone, LIB003 (Lerodalcibep), CSL112: CSL Behring, TQJ230 (pelacarsen), MK-0616, Inclisiran, Ertugliflozin, Tetrahydrobiopterin, MEDI6570, GFH312, and others
• The Atherosclerotic Cardiovascular Disease epidemiology based on gender analyzed that men bear a greater burden than women regarding Atherosclerotic Cardiovascular Disease (ASCVD) in the 7MM
• The Atherosclerotic Cardiovascular Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Atherosclerotic Cardiovascular Disease pipeline products will significantly revolutionize the Atherosclerotic Cardiovascular Disease market dynamics.

Atherosclerotic Cardiovascular Disease Overview
Atherosclerotic cardiovascular disease (ASCVD) refers to a group of conditions caused by the buildup of plaque in the arteries, leading to reduced blood flow to the heart, brain, or other parts of the body. Atherosclerosis is the underlying process in ASCVD, characterized by the accumulation of cholesterol, fatty substances, cellular waste products, calcium, and other substances within the walls of arteries.

Get a Free sample for the Atherosclerotic Cardiovascular Disease Market Report:
https://www.delveinsight.com/report-store/atherosclerotic-cardiovascular-disease-ascvd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Atherosclerotic Cardiovascular Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Atherosclerotic Cardiovascular Disease Epidemiology Segmentation:
The Atherosclerotic Cardiovascular Disease market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Atherosclerotic Cardiovascular Disease
• Prevalent Cases of Atherosclerotic Cardiovascular Disease by severity
• Gender-specific Prevalence of Atherosclerotic Cardiovascular Disease
• Diagnosed Cases of Episodic and Chronic Atherosclerotic Cardiovascular Disease

Download the report to understand which factors are driving Atherosclerotic Cardiovascular Disease epidemiology trends @ Atherosclerotic Cardiovascular Disease Epidemiology Forecast
https://www.delveinsight.com/sample-request/atherosclerotic-cardiovascular-disease-ascvd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Atherosclerotic Cardiovascular Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Atherosclerotic Cardiovascular Disease market or expected to get launched during the study period. The analysis covers Atherosclerotic Cardiovascular Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Atherosclerotic Cardiovascular Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Atherosclerotic Cardiovascular Disease Therapies and Key Companies
• Olpasiran: Amgen
• Ziltivekimab: Novo Nordisk A/S
• Olezarsen: Ionis Pharmaceuticals
• Obicetrapib(TA-8995): NewAmsterdam Pharma
• Apabetalone: ResverlogixCorp
• LIB003 (Lerodalcibep): LIB Therapeutics
• CSL112: CSL Behring
• TQJ230 (pelacarsen): Novartis Pharmaceuticals
• MK-0616: Merck Sharp & Dohme LLC
• Inclisiran: Novartis Pharmaceuticals
• Ertugliflozin: Merck Sharp & Dohme LLC
• Tetrahydrobiopterin: BioMarin Pharmaceutical
• MEDI6570: AstraZeneca
• GFH312: Zhejiang Genfleet Therapeutics Co., Ltd.

Discover more about therapies set to grab major Atherosclerotic Cardiovascular Disease market share @ Atherosclerotic Cardiovascular Disease Treatment Market
https://www.delveinsight.com/sample-request/atherosclerotic-cardiovascular-disease-ascvd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Atherosclerotic Cardiovascular Disease Market Strengths
• Robust pipeline of drugs targeting a variety of different and more effective pathogenic mechanisms in Atherosclerotic Cardiovascular Disease (ASCVD).

Atherosclerotic Cardiovascular Disease Market Opportunities
• The lack of FDA-approved treatments for lowering Lp(a)presents an exciting opportunity for focused research on developing precise therapies in the realm of ASCVD

Scope of the Atherosclerotic Cardiovascular Disease Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Atherosclerotic Cardiovascular Disease Companies: Amgen, Novo Nordisk A/S, Ionis Pharmaceuticals, NewAmsterdam Pharma, ResverlogixCorp, LIB Therapeutics, Novartis, Merck Sharp & Dohme LLC, Novartis Pharmaceuticals, BioMarin Pharmaceutical, AstraZeneca, Zhejiang Genfleet Therapeutics Co., Ltd., and others
• Key Atherosclerotic Cardiovascular Disease Therapies: Olpasiran, Ziltivekimab, Olezarsen, Obicetrapib(TA-8995), Apabetalone, LIB003 (Lerodalcibep), CSL112: CSL Behring, TQJ230 (pelacarsen), MK-0616, Inclisiran, Ertugliflozin, Tetrahydrobiopterin, MEDI6570, GFH312, and others
• Atherosclerotic Cardiovascular Disease Therapeutic Assessment: Atherosclerotic Cardiovascular Disease current marketed and Atherosclerotic Cardiovascular Disease emerging therapies
• Atherosclerotic Cardiovascular Disease Market Dynamics: Atherosclerotic Cardiovascular Disease market drivers and Atherosclerotic Cardiovascular Disease market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Atherosclerotic Cardiovascular Disease Unmet Needs, KOL's views, Analyst's views, Atherosclerotic Cardiovascular Disease Market Access and Reimbursement

To know more about Atherosclerotic Cardiovascular Disease companies working in the treatment market, visit @ Atherosclerotic Cardiovascular Disease Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/atherosclerotic-cardiovascular-disease-ascvd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Atherosclerotic Cardiovascular Disease Market Report Introduction
2. Executive Summary for Atherosclerotic Cardiovascular Disease
3. SWOT analysis of Atherosclerotic Cardiovascular Disease
4. Atherosclerotic Cardiovascular Disease Patient Share (%) Overview at a Glance
5. Atherosclerotic Cardiovascular Disease Market Overview at a Glance
6. Atherosclerotic Cardiovascular Disease Disease Background and Overview
7. Atherosclerotic Cardiovascular Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Atherosclerotic Cardiovascular Disease
9. Atherosclerotic Cardiovascular Disease Current Treatment and Medical Practices
10. Atherosclerotic Cardiovascular Disease Unmet Needs
11. Atherosclerotic Cardiovascular Disease Emerging Therapies
12. Atherosclerotic Cardiovascular Disease Market Outlook
13. Country-Wise Atherosclerotic Cardiovascular Disease Market Analysis (2020-2034)
14. Atherosclerotic Cardiovascular Disease Market Access and Reimbursement of Therapies
15. Atherosclerotic Cardiovascular Disease Market Drivers
16. Atherosclerotic Cardiovascular Disease Market Barriers
17. Atherosclerotic Cardiovascular Disease Appendix
18. Atherosclerotic Cardiovascular Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Latest Reports By DelveInsight:

Telemedicine Service Market https://www.delveinsight.com/report-store/telemedicine-service-market
Telemedicine Service Market By Service Type (Tele Consulting And Tele Monitoring), By Application (Telepathology, Telecardiology, Teleradiology, Teledermatology, Telepsychiatry, Other Services), By End-User (Healthcare Facilities And Homecare), by geography, is projected to grow at a significant CAGR forecast till 2028 owing to the sudden outbreak of covid-19 pandemic and shifting focus for reducing the burden of healthcare cost

Wearable Medical Devices Market https://www.delveinsight.com/report-store/wearable-medical-devices-market
Wearable Medical Devices Market By Device Type (Diagnostic And Monitoring Devices [Vital Sign Monitoring Devices, Sleep Monitoring Devices, Electrocardiographs Fetal And Obstetric Devices, Neuromonitoring Devices, And Others] And Therapeutic Devices [Pain Management Devices, Rehabilitation Devices, Respiratory Therapy Devices, And Others]), By Product Type (Wristband, Headband, Ear Wear, Watch, And Others), By Application (Sports And Fitness, Remote Patient Monitoring, And Home Healthcare), By Distribution Channel (Online And Offline), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to a rise in the geriatric population and increasing prevalence of chronic diseases across the globe.

Surgical Robotic System Market https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical Robotic Systems Market By Application (Urology, Gynecology, Neurosurgery, Orthopedics, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), And by geography is estimated to register appreciable CAGR forecast till 2028 owing to increase in surgical procedures and rising popularity of minimally invasive surgical interventions.

Cancer Diagnostics Market
https://www.delveinsight.com/report-store/cancer-diagnostic-market
Cancer Diagnostics Market By Type (Product Type [Reagent & Kits and Instruments], and Services), Technique (Molecular Diagnostics [Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescent In-Situ Hybridization (FISH), Microarray, and Immunohistochemistry], Diagnostics Imaging [Ultrasound & Radiology, Mammography, MRI Scan, CT Scan, and Nuclear Medicine Scans], Endoscopy, and Biopsy [Standard Biopsy and Liquid Biopsy]), Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Others), End-User (Hospitals, Diagnostics Labs, and Others), and Geography, is expected to grow at a significant CAGR forecast till 2028 owing to the growing burden of cancer across the globe and rise in various product launches for efficient detection of cancer.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to lauch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.